Other Global Peers |
GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), CUREVAC NV (NASDAQ), INNOVENT BIO (HKEx), REPLIGEN CORP (NASDAQ), CANSINOBIO-B (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SINOPHARM (HKEx), JUNSHI BIO (HKEx), ALLAKOS INC (NASDAQ), REMEGEN-B (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), AKESO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), SH PHARMA (HKEx), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), HYGEIA HEALTH (HKEx), BAIYUNSHAN PH (HKEx), REATA PHARMACEUTICALS INC (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), EVEREST MED-B (HKEx), CHINARES PHARMA (HKEx), IGM BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), SIMCERE PHARMA (HKEx), CMS (HKEx), HENLIUS-B (HKEx), CHINAGRANDPHARM (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), ZYMEWORKS INC (NYSE), TRAD CHI MED (HKEx), ADC THERAPEUTICS SA (NYSE), Kimia Farma Tbk. (IDX), QUANTERIX CORPORATION (NASDAQ), OCUMENSION-B (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), HEPALINK (HKEx), PRAXIS PRECISION MEDICINES INC (NASDAQ), INNOCARE-B (HKEx), Y-MABS THERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), SSY GROUP (HKEx), SILVERBACK THERAPEUTICS INC (NASDAQ), ANTENGENE-B (HKEx), KINNATE BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CSTONE PHARMA-B (HKEx), CULLINAN MANAGEMENT INC (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), KEROS THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), UNITED LAB (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), TCR2 THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), ATHENEX INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), TONGRENTANGCM (HKEx), TARSUS PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), IMMUNOTECH-B (HKEx), GOSSAMER BIO INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), HUA MEDICINE-B (HKEx), Soho Global Health Tbk. (IDX), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), GRAYBUG VISION INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERU INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), SHINEWAY PHARM (HKEx), BEYONDSPRING INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CRINETICS PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), AC IMMUNE SA (NASDAQ), 89BIO INC (NASDAQ), FUSEN PHARM (HKEx), KALA PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), CLENE INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), TFF PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), IMMUNIC INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), TRICIDA INC (NASDAQ), TOT BIOPHARM-B (HKEx), HOOKIPA PHARMA INC (NASDAQ), GALECTO INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), LANNETT CO INC (NYSE), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), DAWNRAYS PHARMA (HKEx), SOL GEL TECHNOLOGIES LTD (NASDAQ), IMARA INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), EVOLUS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), PROPHASE LABS INC (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ZHONGZHIPHARM (HKEx), RACE ONCOLOGY LTD (ASX), NEUBASE THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), CH BIOTECH SER (HKEx), EYENOVIA INC (NASDAQ), CRESO PHARMA LTD (ASX), GENPREX INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), BIOMX INC (NYSE American), AILERON THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), LYRA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), Phapros Tbk. (IDX), IX Biopharma (SGX), LIQUIDIA CORPORATION (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), IP (SET), CORVUS PHARMACEUTICALS INC (NASDAQ), NC HEALTHCARE (HKEx), APTORUM GROUP LIMITED (NASDAQ), Merck Tbk. (IDX), NOXOPHARM LTD (ASX), CYCLERION THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), NEW RAY MEDIC (HKEx), LANTERN PHARMA INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), F-STAR THERAPEUTICS INC (NASDAQ), Hyphens Pharma (SGX), OCUPHIRE PHARMA INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), PAK FAH YEOW (HKEx), ALLENA PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), CHARMACY PHAR (HKEx), ARIDIS PHARMACEUTICAL INC (NASDAQ), NEP INTERLONG (HKEx), PALLA PHARMA LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), ANNOVIS BIO INC (NYSE American), INHIBIKASE THERAPEUTICS INC (NASDAQ), EXOPHARM LTD (ASX), VIRIOS THERAPEUTICS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), WAI YUEN TONG (HKEx), MEDLAB CLINICAL LIMITED (ASX), AERPIO PHARMACEUTICALS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), INVION LTD (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), EXTRAWELL PHAR (HKEx), PANBELA THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), BAUDAX BIO INC (NASDAQ), MANNATECH INC (NASDAQ), JCT (SET), CHINA SXT PHARMACEUTICALS INC (NASDAQ), SANAI HEALTH GP (HKEx), PURAPHARM (HKEx), ACRUX (ASX), MILLENDO THERAPEUTICS INC (NASDAQ), TALI DIGITAL LIMITED (ASX), PHARMAXIS (ASX), HOTH THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), TELIGENT INC NEW (NASDAQ), SINOLIFE UTD (HKEx), FIJI KAVA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), PASHUN INT'L (HKEx), Pharmesis Intl (SGX) |